The decisions that made it
The Loss Leader · Business Model
Intuitive Doesn't Give Away the Razor. It Sells the Blade a Chip Won't Let You Refuse.
The myth says Intuitive subsidizes the $2M da Vinci to print money on instruments. The 10-K says otherwise: 67% blended gross margin, and a system priced at up to $3.1M that the math strongly suggests is no loss-leader. The real lock-in is a chip that counts your uses and 9,902 hospitals that can't walk away.
8 min
Ecosystem Lock-In · Moat & Competition
Intuitive Doesn't Sell Robots. It Sells the Razor and Owns Every Blade.
A da Vinci robot costs a hospital well over a million dollars up front. That's the bait. The real business is the per-procedure stream behind it: 84% of Intuitive's 2024 revenue was recurring, and it built a lock-in so complete a rival could only attack it in court.
8 min
The Moat Anatomy · Moat & Competition
Intuitive's Patents Expired. Its Installed Base Kept Growing Anyway.
Everyone waited for patent expiry to unleash a flood of rivals against Intuitive Surgical. It came - and Intuitive's da Vinci fleet kept growing anyway, reaching 11,106 systems by end-2025, up from 9,902 a year earlier, well after the core patent-expiry window had closed. The moat was never the patents.
8 min
The Moat Anatomy · Moat & Competition
Intuitive Surgical's Moat Isn't the Patents. It's Three Walls Stacked on Each Other.
Everyone points at Intuitive's 4,800-plus patents. But the early ones were licensed from SRI and IBM, and the patent wall is aging out. The real moat is a triple lock - trained surgeons, usage-counted instruments, 25 years of clinical evidence - and a rival has to beat all three at once.
8 min